The Latest in Pediatric Dermatology Education
The Premier Event in Medical & Aesthetic Dermatology
For over 30 years, the Masters of Pediatric Dermatology Symposium has grown to reach thousands of clinicians with the goal of promoting and advancing the care of skin diseases in pediatric age groups. The annual event offers the opportunity to exchange new and valuable information between physicians and health professionals interested in cutting-edge pediatric dermatology.
The MOPD Experience
World-renowned clinical faculty members
In-depth & comprehensive pediatric dermatology training from infants to adolescents
Latest resources, tools, and technologies in the field
Atopic Dermatitis Therapy
Bacterial Infection in Kids
Children’s Hair Disorders
COVID Lesions in Children’s Skin
Dermatoses in Neonates and Infants
Orphan Skin Diseases
Pediatric Skin of Color
Pediatric Wound Healing
Sunscreens and Insect Repellent Issues
Warts & Molluscum
Lawrence A. Schachner, MD, is a Professor in the Department of Dermatology, Professor of Pediatrics, and Co-Director of the Division of Pediatric Dermatology at the University of Miami, Miller School of Medicine. He is also Chair Emeritus of the Department of Dermatology and the Stiefel Chair.
Dr. Schachner has written over 200 scientific publications and is best known as the lead author of the textbook “Pediatric Dermatology”. In 2004, Dr. Schachner was named “Practitioner of the Year” by the Florida Society of Dermatology and Dermatologic Surgery, where nearly 800 dermatologists in the state lauded him for his longtime commitment to pediatric dermatology. He is a past president of the American Society for Pediatric Dermatology, and has been cited in numerous periodicals of best doctors, including The Best Doctors in America 1992 to present, Who’s Who in America, and the Guide to Top Doctors. Dr. Schachner’s interests include bioengineered skin in pediatric wounds, skin infections, infestations in children, sun protection in childhood, cutaneous signs of child and sexual abuse, and new therapeutic modalities for acne, eczema, and Epidermolysis Bullosa.